Partial segmental thrombosis of the corpus cavernosum (PSTCC) is a rare disease predominantly occurring in young men. Cardinal symptoms are pain and perineal swelling. Although several risk factors are described in the literature, the exact etiology of penile thrombosis remains unclear in most cases. MRI or ultrasound (US) is usually used for diagnosing this condition.
Case presentation
We report a case of penile thrombosis after left-sided varicocele ligature in a young patient. The diagnosis was established using contrast-enhanced ultrasound (CEUS) and was confirmed by contrast-enhanced magnetic resonance imaging (ceMRI). Successful conservative treatment consisted of systemic anticoagulation using low molecular weight heparin and acetylsalicylic acid.
Conclusion
PSTCC is a rare condition in young men and appears with massive pain and perineal swelling. In case of suspected PSTCC utilization of CEUS may be of diagnostic benefit.
The online version of this article (doi:10.1186/1471-2490-14-100) contains supplementary material, which is available to authorized users.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SS and DK performed CEUS. JPG and BP evaluated MRI. BP mainly coordinated the development of the manuscript. TG and ASK assisted in both imaging modalities and helped to design, coordinate and draft the manuscript. TAB as well as JPG advanced the manuscript by revising it critically for important intellectual content. All authors read and approved the final manuscript.
Abkürzungen
PSTCC
Partial segmental thrombosis of the corpus cavernosum
ceMRI
Contrast-enhanced magnetic resonance imaging
CEUS
Contrast-enhanced ultrasound.
Background
Partial segmental thrombosis of the corpus cavernosum (PSTCC) is a rare disease predominantly occurring in young men [1]. Priapism (prolonged and painful penile erection) must be discerned from actual thrombosis of the corpus cavernosum [2]. PSTCC is characterized by thrombosis that most often is unilateral andlocated in the proximal part of the corpus cavernosum. Cardinal symptoms are massive pain and perineal swelling [3]. The etiology of penile thrombosis remains unclear. Several risk factors are described in the literature [2‐6]. In most patients an excellent outcome is achieved with conservative treatment [7, 8].
MRI or ultrasound (US) are usually used for diagnosis [9]. This report describes the use of contrast-enhanced ultrasound (CEUS) for assessment of penile thrombosis.
Anzeige
Case presentation
A 23-year-old male was admitted to our university hospital with severe pain and a history of progressive perineal swelling over a period of two weeks. His medical history was non-contributory except a left-sided varicocele ligature performed six years ago. No sexual trauma, dysuria or urethral discharge was reported by the patient. Excessive bicycle riding, masturbation, marijuana or cocaine consumption as well as recent long distance flights were negated.
Physical examination confirmed the absence of priapism. A firm, fixed and extremely painful mass was palpable at the proximal penis. The complete blood count, electrolytes, coagulation profile, CRP and urine analysis were unremarkable.Gray-scaled ultrasound (Siemens Acuson S2000, Siemens Sector Healthcare, Erlangen, Germany) combined with color Doppler of the penis using a 6 MHz transducer (Siemens 6C1 HD, Siemens Sector Healthcare, Erlangen, Germany) revealed an elongated hypoechogenic mass (Figure 1, arrow) with irregular hyperechogenic internal echoes. Color Doppler ultrasound demonstrated absence of flow within the inhomogeneous mass (Figure 2, arrow).Contrast-enhanced ultrasound (Acuson Sequoia with 4 MHz transducer, Siemens Sector Healthcare, Erlangen, Germany; 1.2 ml SonoVue®, Bracco Imaging, Milano, Italy) revealed a lack of contrast enhancement in the hypoechogenic mass. This was interpreted as segmental thrombosis of the corpus cavernosum (Figure 3, arrow).For confirmation of this diagnosis a MRI study (1.5 T Siemens Avanto, Siemens Sector Healthcare, Erlangen, Germany) of the pelvis was performed. Transversal T2-weighted images of the pelvis showed a hypointense thrombus of the right proximal corpus cavernosum (Figure 4a, white arrow). T1-weighted fat saturated transversal scans after intravenous contrast medium injection (Gadovist®, Bayer HealthCare AG, Leverkusen, Germany) revealed an intermediate signal and a lack of contrast uptake in the right proximal corpus cavernosum (Figure 4b, black arrow) consistent with sub-acute partial segmental thrombosis of the corpus cavernosum.
×
×
×
×
Conservative treatment was initiated and consisted of anticoagulation with low molecular weight heparin (Enoxaparin 40 mg once daily) and acetylsalicylic acid (100 mg once daily).
Discussion
Partial segmental thrombosis of the corpus cavernosum (PSTCC) is a rare urological disease which primarily occurs in young men with a mean age of 30 years (range 18–59 years) [1]. Differential diagnoses include inflammatory processes as well as solid tumors [10].
Anzeige
PSTCC´s etiology is poorly understood. Although several risk factors have been described, the exact etiology still remains unclear. Recently Ilicki et al. [1] postulated a two-hit model in which first a transverse membrane, dividing the corpus into a proximal and distal portion, and second a triggering event (microtrauma) is required for the emergence of corpus cavernosum thrombosis. In the presented case no solid membrane as a potentially flow-limiting factor was identified, neither in CEUS nor in MRI. Such membranes may predestinate the emergence of PSTCC but their presence may not be mandatory.
Risk factors for development of PSTCC include haematological abnormalities (sickle cell disease, leukemia, homocysteinemia), abuse of alcohol or drugs (marijuana, cocaine), hypercoagulability associated with malignancy and long distance flights as well as microtrauma after coitus or extended cycling [1‐6].
Imaging
Standard imaging modalities include color coded duplex sonography, MRI and CT imaging. The benefits of contrast enhanced MRI have been demonstrated by several authors [1, 2, 6, 11]. In recent years, CEUS has been found to be a cost- efficient alternative in diagnosis of organ and soft tissue pathologies, especially in patients with contraindications for MRI.
This case report outlines the utility of CEUS as an additional cost-saving diagnostic tool for assessment of PSTCC, especially in patients with contraindications for MRI.
Treatment
The first cases of PSTCC were described in 1976 [12]. At that time surgical treatment was the method of choice. Nowadays, as in this case, conservative treatment with systemic anticoagulation appears to be an excellent and reliable therapeutic option. Recent literature shows that all patients treated conservatively have maintained erectile function [5, 7, 8, 13]. Surgery is reserved for patients in whom conservative management fails [5].
Conclusions
PSTCC is a rare condition that predominantly occurs in young men and is accompanied with massive pain and perineal swelling. There are several risk factors described, including abuse of alcohol or drugs, hypercoagulability associated with malignancy and long distance flights as well as microtrauma after coitus or extended bicycle riding. CEUS may be of diagnostic benefit if one suspects PSTCC. Larger studies are warranted to verify this hypothesis. Conservative treatment with systemic anticoagulation has shown excellent results concerning pain relief and erectile dysfunction.
Consent
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Acknowledgements
This publication was funded by the German Research Foundation (DFG) and the University of Würzburg in the funding programme Open Access Publishing.
Anzeige
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The authors declare that they have no competing interests.
Authors’ contributions
SS and DK performed CEUS. JPG and BP evaluated MRI. BP mainly coordinated the development of the manuscript. TG and ASK assisted in both imaging modalities and helped to design, coordinate and draft the manuscript. TAB as well as JPG advanced the manuscript by revising it critically for important intellectual content. All authors read and approved the final manuscript.
Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.
Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.
Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.
Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.
Update Urologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.